Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

Related Articles by Review for PubMed (Select 19720969)

1.

Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.

Welch HG, Albertsen PC.

J Natl Cancer Inst. 2009 Oct 7;101(19):1325-9. doi: 10.1093/jnci/djp278. Epub 2009 Aug 31.

2.

Population screening for prostate cancer and emerging concepts for young men.

Moul JW.

Clin Prostate Cancer. 2003 Sep;2(2):87-97. Review.

PMID:
15040869
3.

Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Schröder FH.

Can J Urol. 2005 Feb;12 Suppl 1:2-6; discussion 92-3. Review.

PMID:
15780157
4.

Impact of screening on incidence and mortality of prostate cancer in the United States.

Potosky AL, Feuer EJ, Levin DL.

Epidemiol Rev. 2001;23(1):181-6. Review.

5.

Impact of screening on prostate cancer rates and trends.

Mettlin C.

Microsc Res Tech. 2000 Dec 1;51(5):415-8. Review.

PMID:
11074610
6.

Screening for prostate cancer: an updated review.

Marta GN, Hanna SA, Fernandes da Silva JL, Carvalho Hde A.

Expert Rev Anticancer Ther. 2013 Jan;13(1):101-8. doi: 10.1586/era.12.154. Review.

PMID:
23259431
7.

Should prostate-specific antigen screening be offered to asymptomatic men?

van Vugt HA, Bangma CH, Roobol MJ.

Expert Rev Anticancer Ther. 2010 Jul;10(7):1043-53. doi: 10.1586/era.10.64. Review.

PMID:
20645694
8.

PSA-based screening for prostate cancer. Too many adverse effects.

[No authors listed]

Prescrire Int. 2012 Sep;21(130):215-7. Review.

PMID:
23016259
9.

Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence.

Hayes JH, Barry MJ.

JAMA. 2014 Mar 19;311(11):1143-9. doi: 10.1001/jama.2014.2085. Review.

PMID:
24643604
10.

Prostate cancer epidemiology in the United States.

Brawley OW.

World J Urol. 2012 Apr;30(2):195-200. doi: 10.1007/s00345-012-0824-2. Epub 2012 Apr 5. Review.

PMID:
22476558
11.

Unanswered questions in screening for prostate cancer.

Neal DE, Leung HY, Powell PH, Hamdy FC, Donovan JL.

Eur J Cancer. 2000 Jun;36(10):1316-21. Review.

PMID:
10882874
12.

Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer.

Wilt TJ.

Semin Urol Oncol. 2002 Feb;20(1):10-7. Review.

PMID:
11828353
13.

A literature review of cost-effectiveness analyses of prostate-specific antigen test in prostate cancer screening.

Garg V, Gu NY, Borrego ME, Raisch DW.

Expert Rev Pharmacoecon Outcomes Res. 2013 Jun;13(3):327-42. doi: 10.1586/erp.13.26. Review.

PMID:
23763530
14.

Landmarks in prostate cancer screening.

Schröder FH.

BJU Int. 2012 Oct;110 Suppl 1:3-7. doi: 10.1111/j.1464-410X.2012.011428.x. Review.

PMID:
23046034
15.

American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.

Carter HB.

BJU Int. 2013 Sep;112(5):543-7. doi: 10.1111/bju.12318. Review.

PMID:
23924423
16.

Update on screening in prostate cancer based on recent clinical trials.

Sciarra A, Cattarino S, Gentilucci A, Salciccia S, Alfarone A, Mariotti G, Innocenzi M, Gentile V.

Rev Recent Clin Trials. 2011 Jan;6(1):7-15. Review.

PMID:
20868347
17.

Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in China.

Zhang L, Wu S, Guo LR, Zhao XJ.

Asian J Androl. 2009 Jan;11(1):9-13. doi: 10.1038/aja.2008.21. Epub 2008 Dec 1. Review.

18.

Risk stratification in prostate cancer screening.

Roobol MJ, Carlsson SV.

Nat Rev Urol. 2013 Jan;10(1):38-48. doi: 10.1038/nrurol.2012.225. Epub 2012 Dec 18. Review. Erratum in: Nat Rev Urol. 2013 May;10(5):248.

PMID:
23247693
19.

Overdiagnosis and overtreatment of prostate cancer.

Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter HB, Carroll P, Etzioni R.

Eur Urol. 2014 Jun;65(6):1046-55. doi: 10.1016/j.eururo.2013.12.062. Epub 2014 Jan 9. Review.

PMID:
24439788
20.

The epidemiology of high-risk prostate cancer.

Punnen S, Cooperberg MR.

Curr Opin Urol. 2013 Jul;23(4):331-6. doi: 10.1097/MOU.0b013e328361d48e. Review.

PMID:
23619582
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk